Suprachoroidal Sustained-Release OXU-001 Compared to Intravitreal Ozurdex® in the Treatment of Diabetic Macular Edema

NCT05697809 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

3

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: OXU-001
DEVICE: Semi-automated suprachoroidal illuminated microcatheter
DRUG: Ozurdex® Ophthalmic Intravitreal Implant

Sponsor

Oxular Limited